Irish Mirror on MSN12h
Obesity meds could be used to help heavy drinkers cut down on booze, study showsUse precise geolocation data. Actively scan device characteristics for identification. Store and/or access information on a ...
Irish Independent on MSN16h
Patients taking weight-loss jabs at clinic had ‘significant reduction’ in alcohol intake, study showsHeavy drinkers who were taking weight-loss jabs in a Dublin clinic significantly reduced their alcohol intake down from 12 to four pints a week, according to a new study. The research was carried ...
A recent breakthrough in medical research offers exciting possibilities for people dealing with diabetes and obesity. This ...
The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.
The US FDA approved the first generic referencing Victoza, a GLP-1 receptor agonist indicated to improve glycemic control.
The move intensifies an ongoing legal battle, as Novo Nordisk joins its major competitor Eli Lilly in opposing a recent initiative by the Outsourcing Facilities Association to include liraglutide in ...
By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers ...
For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...
Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback